Facial plastic surgery & aesthetic medicine · 2026
Cost-Effectiveness of Free Tissue Transfer for Unilateral Facial Paralysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shah Rema, Tyagi Sidharth, Munshi Muhammad, Gadkaree Shekhar K, Lee Yan H, Mohan Suresh
Аннотация
OBJECTIVE: To determine the cost-effectiveness of single-stage free tissue transfer techniques as compared to no intervention for the treatment of chronic facial paralysis.
METHODS: The health utility values specific to unilateral facial paralysis and post-facial reanimation, as well as the cost and success rate of free tissue transfer, were derived from the published literature. Decision tree modeling with Monte Carlo simulation was used to calculate cost-effectiveness. A sensitivity analysis tested the validity of the conclusions by modeling variations in cost and utility values.
RESULTS: The surgical pathway is $141,277 more costly and 2.49 quality-adjusted life years (QALY) more effective than no intervention. The incremental cost-effectiveness ratio between the two pathways is $56,737.80/QALY. At a willingness to pay (WTP) threshold of $100,000 and $150,000, the surgery is cost-effective across all parameters tested (maximum cost end-point being $180,000).
CONCLUSION: Despite the imperfect success rate and risks involved, free tissue transfer surgery is a cost-effective treatment for facial paralysis as compared to no intervention.
METHODS: The health utility values specific to unilateral facial paralysis and post-facial reanimation, as well as the cost and success rate of free tissue transfer, were derived from the published literature. Decision tree modeling with Monte Carlo simulation was used to calculate cost-effectiveness. A sensitivity analysis tested the validity of the conclusions by modeling variations in cost and utility values.
RESULTS: The surgical pathway is $141,277 more costly and 2.49 quality-adjusted life years (QALY) more effective than no intervention. The incremental cost-effectiveness ratio between the two pathways is $56,737.80/QALY. At a willingness to pay (WTP) threshold of $100,000 and $150,000, the surgery is cost-effective across all parameters tested (maximum cost end-point being $180,000).
CONCLUSION: Despite the imperfect success rate and risks involved, free tissue transfer surgery is a cost-effective treatment for facial paralysis as compared to no intervention.